RWA Wealth Partners LLC Purchases 149 Shares of HCA Healthcare, Inc. (NYSE:HCA)

RWA Wealth Partners LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 8.7% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,867 shares of the company’s stock after acquiring an additional 149 shares during the period. RWA Wealth Partners LLC’s holdings in HCA Healthcare were worth $560,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare during the fourth quarter worth approximately $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $36,000. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at $39,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its position in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.1 %

HCA opened at $345.86 on Wednesday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a fifty day moving average price of $325.79 and a two-hundred day moving average price of $340.25. The company has a market cap of $85.15 billion, a P/E ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the firm earned $5.90 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend was Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on HCA shares. Barclays decreased their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Bank of America reduced their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Finally, Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.